Results

eNauka >  Results >  Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe
Title: Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe
Authors : Weichenthal, Michael; ...; Kandolf, Lidija O; ...; (broj, koautora 22)
Issue Date: 2024
Publication: CANCERS
ISSN: 2072-6694 Cancers Search Idenfier
Type: Article
Collation: vol. 16 br. 21 str. 3558-3558
DOI: 10.3390/cancers16213558
WoS-ID: 001351088100001
Scopus-ID: 2-s2.0-85208390357
URI: https://enauka.gov.rs/handle/123456789/947261
Project: Merck Sharp Dohme LLC
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21M21

1
SCOPUSTM
1
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.